BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26337302)

  • 21. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
    Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
    Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical features and prognosis of intraductal papillary mucinous neoplasms of pancreas: analysis of 38 cases].
    Lou WH; Wang DS; Ji Y; Xu XF; Kuang TT; Ni XL; Wu WC; Jin DY
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):947-50. PubMed ID: 16759531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic pancreatis and pancreatic carcinoma in the elderly].
    Otte M
    Praxis (Bern 1994); 2005 Jun; 94(22):943-8. PubMed ID: 15986640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer.
    Morganti AG; Falconi M; van Stiphout RG; Mattiucci GC; Alfieri S; Calvo FA; Dubois JB; Fastner G; Herman JM; Maidment BW; Miller RC; Regine WF; Reni M; Sharma NK; Ippolito E; Valentini V
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):911-7. PubMed ID: 25220717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: Long-term outcomes.
    Calvo FA; Sole CV; Atahualpa F; Lozano MA; Gomez-Espi M; Calin A; García-Alfonso P; Gonzalez-Bayon L; Herranz R; García-Sabrido JL
    Pancreatology; 2013; 13(6):576-82. PubMed ID: 24280572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Outcome of 268 patients with pancreatic carcinoma treated surgically].
    Uravic M; Depolo A; Dobrilla-Dintinjana R; Petrosic N; Grbas H; Miletic D; Tomse Z; Kastelan Z
    Zentralbl Chir; 2004 Apr; 129(2):125-9. PubMed ID: 15106045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy.
    Choi Y; Kim TY; Lee KH; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
    J Pain Symptom Manage; 2014 Jul; 48(1):13-25. PubMed ID: 24321510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current diagnosis and treatment of pancreatic cancer].
    Heinrich S; Schäfer M; Bauerfeind P; Pestalozzi BC; Clavien PA
    Praxis (Bern 1994); 2005 Aug; 94(33):1243-54. PubMed ID: 16138769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity.
    Trikudanathan G; Dasanu CA
    South Med J; 2010 Sep; 103(9):903-10. PubMed ID: 20697320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic head carcinoma: clinical analysis of 189 cases.
    Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosquamous carcinoma of the pancreas.
    Hsu JT; Yeh CN; Chen YR; Chen HM; Hwang TL; Jan YY; Chen MF
    Digestion; 2005; 72(2-3):104-8. PubMed ID: 16172546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenocarcinoma of the pancreatic head: a community teaching hospital's experience from 1982 to 1992.
    Falk J; Keidan R; Rigo PK; Dmuchowski C
    Am Surg; 1999 Jan; 65(1):15-8. PubMed ID: 9915524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic adenocarcinoma.
    Howard TJ
    Curr Probl Cancer; 1996; 20(5):281-328. PubMed ID: 8902402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic cancer. Assessment of prognosis by clinical presentation.
    Kalser MH; Barkin J; MacIntyre JM
    Cancer; 1985 Jul; 56(2):397-402. PubMed ID: 4005804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.
    Benavides M; Abad A; Ales I; Carrato A; Díaz Rubio E; Gallego J; García-Foncillas J; Grávalos C; Laquente B; Pericay C; Rivera F; Tabernero J; Aranda E
    Clin Transl Oncol; 2014 Oct; 16(10):865-78. PubMed ID: 24728654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinico-pathological features and survival of patients with malignant exocrine pancreatic neoplasms: The AC Camargo Cancer Center experience.
    Fonseca de Jesus VH; Guedes Camandaroba MP; Spina Donadio MD; Cabral A; Pimentel Muniz T; de Moura Leite L; Ferreira Sant'Ana L; Luiz da Costa W; Curado MP; Coimbra FJF
    J Surg Oncol; 2019 Jan; 119(1):71-78. PubMed ID: 30481379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervix cancer in Tunisia: clinical and pathological study.
    Missaoui N; Hmissa S; Trabelsi A; Frappart L; Mokni M; Korbi S
    Asian Pac J Cancer Prev; 2010; 11(1):235-8. PubMed ID: 20593963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and risk factors for exocrine pancreatic cancer in a Northern African population.
    Sellam F; Harir N; Khaled MB; Mrabent NM; Salah R; Diaf M
    J Gastrointest Cancer; 2015 Jun; 46(2):126-30. PubMed ID: 25737417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017.
    Kang MJ; Lim J; Han SS; Park HM; Park SJ; Won YJ; Kim SW
    Cancer Res Treat; 2022 Jan; 54(1):208-217. PubMed ID: 34030432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.